Switch to:
Horizon Pharma PLC (NAS:HZNP)
EV/EBIT
146.07 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Horizon Pharma PLC's enterprise value is $3,066.1 Mil. Horizon Pharma PLC's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2016 was $21.0 Mil. Therefore, Horizon Pharma PLC's EV/EBIT ratio for today is 146.07.

HZNP' s EV/EBIT Range Over the Past 10 Years
Min: -775.4   Max: 219.8
Current: 146.07

-775.4
219.8

During the past 8 years, the highest EV/EBIT Ratio of Horizon Pharma PLC was 219.80. The lowest was -775.40. And the median was -1.60.

HZNP's EV/EBIT is ranked lower than
97% of the 535 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 21.07 vs. HZNP: 146.07 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Horizon Pharma PLC's enterprise value for the quarter that ended in Sep. 2016 was $3,521.0 Mil. Horizon Pharma PLC's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2016 was $21.0 Mil. Horizon Pharma PLC's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2016 was 0.60%.


Definition

Horizon Pharma PLC's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=3066.066/20.99
=146.07

Horizon Pharma PLC's current Enterprise Value is $3,066.1 Mil.
Horizon Pharma PLC's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2016 was 38.049 (Dec. 2015 ) + -27.204 (Mar. 2016 ) + 31.467 (Jun. 2016 ) + -21.322 (Sep. 2016 ) = $21.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Horizon Pharma PLC's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2016 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Sep. 2016 )=EBIT (TTM)/Enterprise Value (Q: Sep. 2016 )
=20.99/3521.0209
=0.60 %

Horizon Pharma PLC's Enterprise Value for the quarter that ended in Sep. 2016 was $3,521.0 Mil.
Horizon Pharma PLC's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2016 was 38.049 (Dec. 2015 ) + -27.204 (Mar. 2016 ) + 31.467 (Jun. 2016 ) + -21.322 (Sep. 2016 ) = $21.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Horizon Pharma PLC Annual Data

Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebit 0.000.000.000.000.00-0.67-1.12-12.46-203.2267.65

Horizon Pharma PLC Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebit -82.83-63.00-203.22-659.99-190.24137.3667.65145.6938.24167.75
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK